Brain

Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases

Substantial clinical need expected to facilitate rapid overall trial enrollmentHOUSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq:…

6 months ago

CervoMed Announces Late-Breaking Presentations at Alzheimer’s Association® International Congress 2025

BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for…

6 months ago

AIRS Medical Earns Expanded MDR Certification for AI-Powered MRI Image Enhancement Solution SwiftMR™

SEOUL, South Korea, July 8, 2025 /PRNewswire/ -- AIRS Medical, a leader in AI solutions for diagnostic imaging, has received…

6 months ago

Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)

FDA assigns PDUFA target action date of January 5, 2026, for decision on accelerated approvalTividenofusp alfa is designed to deliver…

6 months ago

Salk Institute Study Shows FloraWorks’ CBN Reverses Age-Related Cognitive Decline

Breakthrough findings highlight TruCBN(TM) as a potential therapeutic for brain aging and cognitive health.Portland, Oregon--(Newsfile Corp. - July 7, 2025)…

6 months ago

Esaote presents at ECVS 2025 the new generation of veterinary MRI, Vet -MR Grande ELITE

GENOA, Italy and ANTWERP, Belgium, July 3, 2025 /PRNewswire/ -- Esaote, a leading company in the field of medical diagnostic imaging,…

6 months ago

Apollo Biowellness, Inc. Re-Files Application with OTCMarkets.com

North Bergen, New Jersey--(Newsfile Corp. - July 3, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the "Company") announces that…

6 months ago

Declare Freedom from Discomfort This July — Bestqool’s Non-invasion Red Light Therapy

Let the light lead the way — this July, give yourself the freedom to feel your best. NEW YORK, July…

6 months ago